Disclosure and management of research findings in stem cell research and banking: Policy statement

Rosario Isasi, Bartha M. Knoppers, Peter W. Andrews, Annelien Bredenoord, Alan Colman, Lee Eng Hin, Sara Hull, Ock Joo Kim, Geoffrey Lomax, Clive Morris, Douglas Sipp, Glyn Stacey, Jan Wahlstrom, Fanyi Zeng

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Prompted by an increased interest of both research participants and the patient advocacy community in obtaining information about research outcomes and on the use of their biological samples; the international community has begun to debate the emergence of an ethical 'duty to return research results to participants. Furthermore, the use of new technologies (e.g., whole-genome and -exome sequencing) has revealed both genetic data and incidental findings with possible clinical significance. These technologies together with the proliferation of biorepositories, provide a compelling rationale for governments and scientific institutions to adopt prospective policies. Given the scarcity of policies in the context of stem cell research, a discussion on the scientific, ethical and legal implications of disclosing research results for research participants is needed. We present the International Stem Forum Ethics Working Partys Policy Statement and trust that it will stimulate debate and meet the concerns of researchers and research participants alike.

Original languageEnglish (US)
Pages (from-to)439-448
Number of pages10
JournalRegenerative Medicine
Volume7
Issue number3
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

Stem Cell Research
Disclosure
Stem cells
Research
Exome
Technology
Patient Advocacy
Incidental Findings
Ethics
Research Personnel
Outcome Assessment (Health Care)
Genome
Genes

Keywords

  • best practice
  • biorepository
  • embryonic stem cell
  • ethics
  • induced pluripotent stem cell
  • policy
  • return of research results

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

Isasi, R., Knoppers, B. M., Andrews, P. W., Bredenoord, A., Colman, A., Hin, L. E., ... Zeng, F. (2012). Disclosure and management of research findings in stem cell research and banking: Policy statement. Regenerative Medicine, 7(3), 439-448. https://doi.org/10.2217/rme.12.23

Disclosure and management of research findings in stem cell research and banking : Policy statement. / Isasi, Rosario; Knoppers, Bartha M.; Andrews, Peter W.; Bredenoord, Annelien; Colman, Alan; Hin, Lee Eng; Hull, Sara; Kim, Ock Joo; Lomax, Geoffrey; Morris, Clive; Sipp, Douglas; Stacey, Glyn; Wahlstrom, Jan; Zeng, Fanyi.

In: Regenerative Medicine, Vol. 7, No. 3, 01.05.2012, p. 439-448.

Research output: Contribution to journalReview article

Isasi, R, Knoppers, BM, Andrews, PW, Bredenoord, A, Colman, A, Hin, LE, Hull, S, Kim, OJ, Lomax, G, Morris, C, Sipp, D, Stacey, G, Wahlstrom, J & Zeng, F 2012, 'Disclosure and management of research findings in stem cell research and banking: Policy statement', Regenerative Medicine, vol. 7, no. 3, pp. 439-448. https://doi.org/10.2217/rme.12.23
Isasi, Rosario ; Knoppers, Bartha M. ; Andrews, Peter W. ; Bredenoord, Annelien ; Colman, Alan ; Hin, Lee Eng ; Hull, Sara ; Kim, Ock Joo ; Lomax, Geoffrey ; Morris, Clive ; Sipp, Douglas ; Stacey, Glyn ; Wahlstrom, Jan ; Zeng, Fanyi. / Disclosure and management of research findings in stem cell research and banking : Policy statement. In: Regenerative Medicine. 2012 ; Vol. 7, No. 3. pp. 439-448.
@article{491a46dfd75a483291bf773f79f9cb2a,
title = "Disclosure and management of research findings in stem cell research and banking: Policy statement",
abstract = "Prompted by an increased interest of both research participants and the patient advocacy community in obtaining information about research outcomes and on the use of their biological samples; the international community has begun to debate the emergence of an ethical 'duty to return research results to participants. Furthermore, the use of new technologies (e.g., whole-genome and -exome sequencing) has revealed both genetic data and incidental findings with possible clinical significance. These technologies together with the proliferation of biorepositories, provide a compelling rationale for governments and scientific institutions to adopt prospective policies. Given the scarcity of policies in the context of stem cell research, a discussion on the scientific, ethical and legal implications of disclosing research results for research participants is needed. We present the International Stem Forum Ethics Working Partys Policy Statement and trust that it will stimulate debate and meet the concerns of researchers and research participants alike.",
keywords = "best practice, biorepository, embryonic stem cell, ethics, induced pluripotent stem cell, policy, return of research results",
author = "Rosario Isasi and Knoppers, {Bartha M.} and Andrews, {Peter W.} and Annelien Bredenoord and Alan Colman and Hin, {Lee Eng} and Sara Hull and Kim, {Ock Joo} and Geoffrey Lomax and Clive Morris and Douglas Sipp and Glyn Stacey and Jan Wahlstrom and Fanyi Zeng",
year = "2012",
month = "5",
day = "1",
doi = "10.2217/rme.12.23",
language = "English (US)",
volume = "7",
pages = "439--448",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Disclosure and management of research findings in stem cell research and banking

T2 - Policy statement

AU - Isasi, Rosario

AU - Knoppers, Bartha M.

AU - Andrews, Peter W.

AU - Bredenoord, Annelien

AU - Colman, Alan

AU - Hin, Lee Eng

AU - Hull, Sara

AU - Kim, Ock Joo

AU - Lomax, Geoffrey

AU - Morris, Clive

AU - Sipp, Douglas

AU - Stacey, Glyn

AU - Wahlstrom, Jan

AU - Zeng, Fanyi

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Prompted by an increased interest of both research participants and the patient advocacy community in obtaining information about research outcomes and on the use of their biological samples; the international community has begun to debate the emergence of an ethical 'duty to return research results to participants. Furthermore, the use of new technologies (e.g., whole-genome and -exome sequencing) has revealed both genetic data and incidental findings with possible clinical significance. These technologies together with the proliferation of biorepositories, provide a compelling rationale for governments and scientific institutions to adopt prospective policies. Given the scarcity of policies in the context of stem cell research, a discussion on the scientific, ethical and legal implications of disclosing research results for research participants is needed. We present the International Stem Forum Ethics Working Partys Policy Statement and trust that it will stimulate debate and meet the concerns of researchers and research participants alike.

AB - Prompted by an increased interest of both research participants and the patient advocacy community in obtaining information about research outcomes and on the use of their biological samples; the international community has begun to debate the emergence of an ethical 'duty to return research results to participants. Furthermore, the use of new technologies (e.g., whole-genome and -exome sequencing) has revealed both genetic data and incidental findings with possible clinical significance. These technologies together with the proliferation of biorepositories, provide a compelling rationale for governments and scientific institutions to adopt prospective policies. Given the scarcity of policies in the context of stem cell research, a discussion on the scientific, ethical and legal implications of disclosing research results for research participants is needed. We present the International Stem Forum Ethics Working Partys Policy Statement and trust that it will stimulate debate and meet the concerns of researchers and research participants alike.

KW - best practice

KW - biorepository

KW - embryonic stem cell

KW - ethics

KW - induced pluripotent stem cell

KW - policy

KW - return of research results

UR - http://www.scopus.com/inward/record.url?scp=84861328808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861328808&partnerID=8YFLogxK

U2 - 10.2217/rme.12.23

DO - 10.2217/rme.12.23

M3 - Review article

C2 - 22594334

AN - SCOPUS:84861328808

VL - 7

SP - 439

EP - 448

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 3

ER -